May 12, 2020 / 08:20PM GMT
Lyanne Harrison - BofA Merrill Lynch, Research Division - VP
Hi Rob, I'll get started. Hello, all, and welcome to our conversation with ResMed. My name is Lyanne Harrison, and I'm Bank of America's Australian Health Care Analyst. As you heard, Rob Douglas is also on the phone. He's the COO of ResMed. And Rob held that role of Chief Operating Officer since September 2011. So thank you all for joining us today. Rob, are you still there?
Robert A. Douglas - ResMed Inc. - President & COO
Yes. Yes, Lyanne. I'm sorry for jumping the gun there.
Lyanne Harrison - BofA Merrill Lynch, Research Division - VP
That's all right. That's all right. Why don't you start by taking us -- telling us a little bit more about ResMed?
Robert A. Douglas - ResMed Inc. - President & COO
Sure. Thanks, Lyanne. Just wanted to quickly recap our recent earnings and talk to a little bit about our strategy. ResMed, we've really focused on respiratory care. And in this time of crisis with the COVID
Resmed Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
May 13, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers